FT11. The Optimal Aortic Diameter for Risk of Late Aortic Events in Uncomplicated Stanford Type B Aortic Dissection
Akihito Matsushita, Keita Yumoto, Yu Tsunoda, Takashi Hattori, Wahei Mihara. Seikeikai Chiba Medical Center, Chiba, Japan
Objective: The initial treatment of uncomplicated acute type B aortic dissection (ATBAD) has previously been mainly medication. Almost half of patients require aortic surgery in the chronic phase. The initial aortic diameter is a risk factor for late aortic events in patients with uncomplicated ATBAD. However, the cutoff value remains controversial, 40 mm or 45 mm. We evaluated the optimal aortic diameter for risk of late aortic events in patients with uncomplicated ATBAD.
Methods: We conducted a retrospective cohort study reviewing 175 consecutive patients who underwent initial treatment for uncomplicated ATBAD between October 2004 and May 2017. We excluded 47 patients with complicated ATBAD (rupture, impending rupture, malperfusion). The follow-up rate was 95.4%, with a mean follow-up of 43.8 6 36.4 months. The largest diameters of the minor and major axes were measured on computed tomography at admission and before discharge. All causes of mortality, late aortic events, and operation and indication for operation for dissected aorta were assessed with the Kaplan-Meier method. Logistic regression was used to examine whether aortic diameter is useful in predicting late aortic events. Cox regression was carried out to assess the prognostic effect of aortic diameter after allowing significant covariates, and receiver operating characteristic analyses were used to determine test reliability.
Results: In-hospital mortality was one (0.6%). Long-term mortality was 26 (14.9%). There were 42 patients (24.1%) who underwent late operation for dissected aorta, and 26 patients (14.9%) refused late operation despite a dissected aneurysm of 55 mm or saccular aneurysm. The rate of freedom from these aortic events was 73.5%, 61.2%, and 53.9% at 1 year, 3 years, and 5 years. Receiver operating characteristic analyses showed cutoff values at admission of 40 mm for minor axis diameter with sensitivity of 72.1% and specificity of 83.2% (area under the curve [AUC], 0.81; P < .001) and 41 mm for major axis diameter (AUC, 0.80; P < 0.001); cutoff values before discharge were 39 mm for minor axis diameter (AUC, 0.83; P < .001) and 42 mm for major axis diameter (AUC, 0.85; P < 0.001). After adjustment for other covariates (age, sex, ulcerlike projection, and larger false lumen diameter), minor axis aortic diameter at admission of 40 mm was an independent risk factor of late aortic events (hazard ratio, 4.55, 95% confidence interval, 2.58-8.32; P < .001).
Conclusions: We identify minor axis diameter of 40 mm on computed tomography at admission as the optimal aortic diameter for prediction of late aortic events. Objective: This study was undertaken to evaluate the timing of and potential risk factors associated with reintervention or late intervention after primary thoracic endovascular aortic repair (TEVAR) or medical management alone (MMA) in patients with type B aortic dissection (TBAD).
Methods: Using a population-based health insurance claims database between 2006 and 2014, we identified 653 patients treated by primary TEVAR and 4928 patients treated by primary MMA for TBAD. Aortic procedures were defined if the patients had received repeated TEVAR, open repair for TBAD, embolization for endoleak, or open repair for retrograde type A aortic dissection after TEVAR or MMA. The timing of reintervention or late intervention was estimated on the basis of Kaplan-Meier analysis, and predictors were determined using Cox regression analysis.
Results: Of the patients, 11% (n ¼ 71) and 14% (n ¼ 695) experienced reintervention or late intervention after TEVAR or MMA during a mean of 3.2 (standard deviation, 2.4) and 4.3 (standard deviation, 2.7) years, respectively. Cox regression analysis showed that the patients who were male, were younger, and had a disease history of hypertension and ischemic heart had an increased risk of late intervention after MMA. In addition, patients have a lower risk for repeated TEVAR after TEVAR than the MMA patients with a late intervention of TEVAR (8.4% vs 10.9%; P ¼ .021), whereas there was no difference in the risk of death, open repair for retrograde type A aortic dissection, or the majority of adverse events.
Conclusions: The risk factors of late intervention after MMA for acute TBAD are male sex, younger age, hypertension, and ischemic heart disease. Patients receiving late TEVAR after MMA have a higher incidence of repeated TEVAR than those receiving primary TEVAR for acute TBAD.
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Aneurysm Sac Thrombus Volume Predicts Endoleak With Aneurysm Expansion After Endovascular Aneurysm Repair
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Objective: Several studies have analyzed risk factors that may influence the incidence of endoleak with sac expansion after endovascular aneurysm repair (EVAR). Previous studies demonstrated a quantitative protective effect of intraluminal thrombus for endoleak. However, they assessed the amount of intraluminal thrombus indirectly by thrombus thickness, percentage of circumferential luminal thrombus, thrombus area, and so on. Therefore, the correlation still has not been well demonstrated. The aim of this study was to examine the correlation of preoperative intraluminal thrombus, measured by thrombus volume, with the incidence of endoleak and late sac expansion.
Methods: Between June 2007 and March 2014, there were 423 patients who underwent EVAR at our institution. Ruptured, inflammatory, and infected aneurysms were excluded; 214 patients who had preoperative and postoperative computed tomography angiography (CTA) and at least 3 years of follow-up were included in this study. Prospectively collected data were supplemented with a retrospective review of medical records and radiologic images. The demographic and clinical characteristic profiles were collected. CTA was evaluated with Aquarius iNtuition software (TeraRecon, Foster City, Calif) to obtain aneurysm sac, intraluminal thrombus volume, and other anatomic factors. Late endoleak was defined as a leak observed at 30 days. Significant abdominal aortic aneurysm sac expansion was defined as an increase of 5 mm. Logistic regression and Cox regression analysis were used to assess the association of each variable with the incidence of late endoleak and sac expansion.
Results: Of 214 patients, 49.1% (105 patients) had late endoleak and 19.6% (48 patients) had late endoleak with sac expansion on CTA. The mean follow-up duration was 53.4 months (range, 18.5-109.4 
months).
Univariate analysis demonstrated that number of total patent lumbar arteries (P ¼ .011), a patent inferior mesenteric artery (IMA; P < .01), diameter of IMA (P < .01), Excluder (W. L. Gore & Associates, Flagstaff, Ariz) stent graft (P < .01), smoking history (P ¼ .022), and preoperative intraluminal thrombus volume/sac volume (P ¼ .018) are significant factors regarding the incidence of late endoleak . Logistic regression analysis showed that variables such as diameter of IMA (P ¼ .006), Excluder stent graft use (P < .01), and preoperative intraluminal thrombus volume/sac volume (P ¼ .026) are predictors of incidence of late type II endoleak. Cox regression analysis showed that the preoperative intraluminal thrombus volume/ sac volume is the only significant predictor of incidence of late endoleak with sac expansion (P ¼ .015).
Conclusions: Preoperative aneurysm sac thrombus volume predicts incidence of endoleak with aneurysm expansion after EVAR. Objective: The conventional technique for the treatment of chronic venous insufficiency of the great saphenous vein (GSV) and small saphenous vein consists of high ligation of the saphenofemoral or saphenopopliteal junction accompanied by stripping. Intervention on the GSV has been advocated to stripping of the above-knee GSV because of saphenous nerve injury of GSV stripping. However, in our country, complete removal of the GSV is considered the standard of care. Our objective was to compare treatment of GSV reflux using radiofrequency (RFA) ablation compared with ligation and complete stripping (S&T), from the saphenofemoral junction to the ankle, in patients with chronic venous disease (CVD) and Clinical, Etiology, Anatomy, and Pathophysiology (CEAP) classes 2 to 4.
Methods: Forty-nine patients with CVD and CEAP class 2 to 4 were assessed at baseline, 4 weeks, and 1 year for complications, period of absence from activities, and calculation of the revised Venous Clinical Severity Score and quality of life scores. They were re-examined at 1 year and 3 years after treatment to evaluate recurrence rates.
Results: There were 186 patients referred from primary ambulatory care, of whom 70 (37.6%) met the eligibility criteria; 53 (28.6%) consented to participate. Four patients were excluded after randomization. The final analysis included 49 patients with primary CVD of the saphenous veins, with 26 randomly assigned to the RFA group and 23 to the S&T group. The success rate per limb (P ¼ .540), Venous Clinical Severity Score (P ¼ .636), Aberdeen Varicose Vein Questionnaire score (P ¼ .163), and clinical complications were similar in the two treatment groups. Nevertheless, the S&T group reported a longer time of absence from work or from domestic activities (20.13) than those in the RFA group (8.62). Length of hospitalization was also significantly longer for the S&T group (1.48) than for the RFA group (0.69; P < .0001). The clinical recurrence of varicose veins in 3 years was not significantly different in the two groups (P ¼ .638), with only two cases in the RFA group (8.7%) and three cases in the S&T group (15.8%).
Conclusions: The use of a minimally invasive technique by RFA for the treatment of saphenous reflux with CEAP classes 2, 3, and 4 had a success rate of around 94%. The patients who underwent this procedure displayed improvement in quality of life compared with the traditional technique but spent significantly less time hospitalized and absent from work.
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